Excelsior Biopharma

Excelsior Biopharma EBIT per Share

The EBIT per Share of Excelsior Biopharma (6496.TWO) as of Oct 28, 2026 is -3.82 TWD. In the previous year, EBIT per Share was -1.82 TWD — a change of 110.37% (lower).

EBIT per Share

-3.82TWD

YoY

110.37%

Last updated:

EBIT per Share of Excelsior Biopharma is 2025 -3.82 TWD. EBIT per Share of Excelsior Biopharma was 2024 -1.82 TWD. It decreases by 110.37% lower compared to the previous year.

The Excelsior Biopharma EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2018
6.19 TWD
Jan 1, 2019
1.91 TWD
Jan 1, 2020
1.00 TWD
Jan 1, 2021
-0.02 TWD
Jan 1, 2022
-0.55 TWD
Jan 1, 2023
-1.73 TWD
Jan 1, 2024
-1.82 TWD
Jan 1, 2025
-3.82 TWD
The Excelsior Biopharma EBIT per Share history
YEAREBIT per ShareYoY
-3.82TWD+110.37%
-1.82TWD+5.34%
-1.73TWD+212.07%
-0.55TWD+2,432.37%
-0.02TWD-102.18%
1.00TWD-47.39%
1.91TWD-69.24%
6.19TWD-13.41%
7.15TWD+55.44%
4.60TWD+12.35%
4.10TWD-10.49%
4.58TWD+0.53%
4.55TWD-39.60%
7.54TWD-65.58%
21.90TWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Excelsior Biopharma Stock analysis

What does Excelsior Biopharma do? Excelsior Biopharma Inc., headquartered in Taipei City, Taiwan, operates in the Health Care sector. The company focuses on the research, development, manufacturing, and distribution of pharmaceutical products, including prescription and non-prescription drugs, health care products, medical equipment, and rapid test reagents. Listed on 19 December 2014, Excelsior Biopharma serves both domestic and international markets with its diverse product portfolio. Excelsior Biopharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Excelsior Biopharma stock

EBIT per Share of Excelsior Biopharma is -3.82 TWD in 2025.

EBIT per Share of Excelsior Biopharma changed from -1.82 TWD to -3.82 TWD, representing a 110.37% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Excelsior Biopharma since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Excelsior Biopharma

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Excelsior Biopharma